Taskin Bioregeneration Announces Launch of Phase II/III Clinical Trials for DesRep
Tehran, October 2024 – Taskin Bioregeneration, a pioneering company in regenerative medicine and cell therapy, is proud to announce the […]
Tehran, October 2024 – Taskin Bioregeneration, a pioneering company in regenerative medicine and cell therapy, is proud to announce the […]